LYEL · Lyell Immunopharma, Inc. · Debt
Market Cap
$298.96M
Shares
24.51M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1806952
CUSIP
55083R203
13F (30d)
66 filings
65 filers
Visit website
Investor relations